Resource Center

GLP-1 medication vial and syringe

Weight Loss Injections Online From $89/Month

Weekly GLP-1 weight loss injections prescribed online, no clinic visits. Compounded semaglutide or tirzepatide with supplies, provider care and shipping.

Read More

A woman with graying hair and blue shirt smiles, hand on her chest outdoors.

GLP-1 for Women: Menopause, PCOS & Weight Loss

How GLP-1s work for women facing menopause, PCOS, insulin resistance or plateaus. Safety, birth control interactions and plans starting at $89/month.

Read More

A man with graying hair and a blue shirt smiles subtly in an outdoor setting.

GLP-1 for Men: Belly Fat, Muscle & How to Start

How GLP-1s target visceral belly fat in men while protecting muscle. Compare semaglutide vs tirzepatide, side effects and pricing from $89/month.

Read More

Two pharmaceutical vials, Tirzepatide with a blue cap and Semaglutide with a purple cap.

GLP-1 Without Insurance: Plans From $89/Month

Get GLP-1 weight loss medication without insurance, prior authorization or membership fees. Compounded semaglutide $89/mo, tirzepatide $120/mo, all-in.

Read More

Two pharmaceutical vials, Tirzepatide with a blue cap and Semaglutide with a purple cap.

MaxLife vs Hims 2026: GLP-1 Pricing Compared

See how MaxLife and Hims compare on GLP-1 program pricing, provider access, shipping and cancellation terms.

Read More

A man kisses a smiling woman on a boat ride with bright blue water.

4.7★ on Trustpilot: See Why Patients Trust MaxLife

Curious what weight loss with MaxLife is really like? Read honest reviews from real patients, their results, and why they'd recommend it.

Read More

Two pharmaceutical vials, Tirzepatide with a blue cap and Semaglutide with a purple cap.

Best Tirzepatide Providers of 2026, Ranked

Compare the best compounded tirzepatide providers of 2026 on price, pharmacy transparency, provider-guided dosing and shipping.

Read More

The official logo for the U.S. Food and Drug Administration (FDA)

MaxLife Response to FDA Warning Letter 721453 | Corrective Actions & Status

MaxLife submitted a response to FDA Warning Letter 721453 on Feb 24, 2026. Review corrective actions taken and the current FDA close-out status.

Read More

Semaglutide Tirzepatide vials together

MaxLife vs Ro 2026: Which GLP-1 Plan Is Better?

MaxLife vs Ro head-to-head on compounded semaglutide and tirzepatide pricing, pharmacy transparency, shipping and cancellation.

Read More